Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Zolmitriptan and preparation method thereof

A technology of oxazolidinone and reaction, which is applied in the field of pharmaceutical preparations and can solve problems such as lengthiness

Active Publication Date: 2015-01-07
CHENGDU TIANTAISHAN PHARMA
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0035] The main disadvantages of the method described in WO2005 / 105792 are as follows: it is a multi-step and lengthy process involving 5-7 steps to obtain Zolmitriptan (I) was obtained from the diazonium salt (XV) of -2-ketone (IX); the process involved highly basic conditions that could cleave the oxazolidinone ring; reported overall yields were only 9-22 %

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Zolmitriptan and preparation method thereof
  • Zolmitriptan and preparation method thereof
  • Zolmitriptan and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] Embodiment 1: the preparation of L-4-nitro-phenylalanine

[0105] Reaction formula:

[0106] Feeding ratio: L-phenylalanine 1kg, concentrated sulfuric acid 1700ml, concentrated nitric acid 450ml

[0107] Operation: In a reaction vessel equipped with a thermometer, add concentrated sulfuric acid according to the ratio, cool in an ice-salt bath to below 0°C and start to slowly add concentrated nitric acid dropwise. During the dropping process, control the temperature below 2°C; after dropping, control the temperature below 20°C Add L-phenylalanine in batches; after the addition, remove the ice-salt bath and let it rise to room temperature naturally, and stir for 30 minutes. Pour the reaction solution into 7L of ice water, control the temperature below 5°C while stirring, adjust the pH to 9.5-10.5 with 25% ammonia water, cool and crystallize, filter, and collect the solid; add 14L of hot water to heat and stir to dissolve the solid, and use the amount of feed Stir an...

Embodiment 2

[0108] Embodiment 2: the preparation of L-4-nitrophenylalanine methyl ester

[0109] Reaction formula:

[0110] Feed ratio: L-4-nitro-phenylalanine 720g, thionyl chloride 858ml, anhydrous methanol 3430ml

[0111] Operation: In a reaction vessel equipped with a thermometer, add anhydrous methanol according to the ratio, cool in an ice-salt bath to below 0°C and add thionyl chloride dropwise; after dropping, control the temperature below 2°C and stir for 30 minutes, then add L- 4-Nitro-phenylalanine was stirred in an ice-salt bath for 8 hours, removed from the ice bath, allowed to rise to room temperature naturally, and stirred for reaction. TLC monitors the reaction process (developing agent: chloroform: methanol = 1: 2), after the completion of the reaction (R f =0.8~0.85), use a rotary evaporator (control temperature 85±5°C) to concentrate under reduced pressure until no liquid drops out, add 750ml ice water and 1500mL ethyl acetate, and use saturated Na 2 CO 3 Soluti...

Embodiment 3

[0112] Embodiment 3: Preparation of (S)-3-(4-nitrophenyl)-2-amino-1-propanol

[0113] Reaction formula:

[0114] Feeding ratio: L-4-nitrophenylalanine methyl ester 200g, sodium borohydride 130g, methanol 2000ml, purified water 1000ml

[0115] Operation: In a reaction vessel equipped with a thermometer, add methanol and purified water according to the ratio, cool in an ice-salt bath to below 0°C, and add sodium borohydride in batches (control the reaction temperature not to exceed 2°C). After the addition is completed, add L-4-nitrophenylalanine methyl ester in batches (control the reaction temperature not to exceed 5°C). After the addition, stir and react at 0-5°C for 0.5 hours; then slowly rise to room temperature (about 20°C) , stirred for 3-5 hours; heated in a water bath to 50°C for 2-3 hours, TLC showed that the reaction was complete (developing solvent: dichloromethane: methanol = 2:1). Add 5% activated carbon to the reaction solution, decolorize at 50°C for 20 min...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to zolmitriptan and a preparation method thereof, in particular to the preparation method of zolmitriptan. The preparation method comprises the following steps: (1) reacting (S)-3-(4-nitrophenyl)-2-amino-1-propanol with triphosgene in an organic solvent in the presence of an alkaline reagent, and cyclizing to obtain (S)-4-(4-nitrobenzyl)-2-oxazolidinone; (2) carrying out hydrogenation reduction on (S)-4-(4-nitrobenzyl)-2-oxazolidinone in a solvent in the presence of a catalyst to obtain (S)-4-(4-aminobenzyl)-2-oxazolidinone; (3) carrying out diazo-reaction on (S)-4-(4-aminobenzyl)-2-oxazolidinone in an acidic solution in the presence of a diazotization reagent to obtain (S)-4-(4-hydrazinobenzyl)-2-oxazolidinone; and (4) reacting (S)-4-(4-hydrazinobenzyl)-2-oxazolidinone with 4-(N,N-dimethyl)-amino-dibutyl acetal to generate the zolmitriptan. The zolmitriptan prepared with the method is high in purity.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and relates to a medicine for treating or preventing migraine and a preparation method thereof, in particular to zolmitriptan and a preparation method thereof for treating migraine. The method of the invention prepares Zolmitriptan has good characteristics. Background technique [0002] Migraine is one of clinical common disease, frequently-occurring disease, and its incidence rate is about 10%. The International Headache Society defines migraine as intermittent attacks of headache accompanied by autonomic disturbances. Clinically manifested as paroxysmal headache: often accompanied by dizziness, hearing loss and so on. The incidence of migraine in my country ranges from 4.2% to 14.6%, with a male to female ratio of 1:4. With the acceleration of the pace of life and the increase of work pressure, the incidence of migraine in China is on the rise, and it has become a common ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D413/06A61K31/4178A61P25/06
Inventor 赵东明方专王敬江威张莲莲董国明
Owner CHENGDU TIANTAISHAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products